RESULTS
Among the 445 patients admitted to the tertiary general ICU, 105
patients were found to meet the study inclusion criteria. Twelve
patients with incomplete data were excluded from the study. Data of the
remaining 93 patients were analyzed (Figure 1).
There was no statistically difference between men and women in terms of
the frequency of sarcopenia (p>0.05). BMI was higher in
nonsarcopenic patients than sarcopenic patients (25.6±3.5 vs 24.2±4.8,
p<0.05). Fifty five (59%) of all patients were found as
sarcopenic (p<0.05). The characteristics of the patients,
reasons for admission to the ICU and comorbidities were similar between
goups (p>0.05) (Table 1). The presence of sarcopenia, and
APACHE II and SOFA scores were similar between groups (p>
0.05). Prealbumin levels were significantly lower in the sarcopenic
group (p <0.001). Vit D, albumin, urea, creatinine, nutrition
status and mechanical ventilation time were not different between the
groups (p> 0.05). The length of stay in ICU and in hospital
were 27.8±29.7 and 33.0±31.2 days in sarcopenic patients, 15.1±17 and
23.8±21.3 days in nonsarcopenic patients respectively (p
<0.05). Mortality was found to be 49.1% in patients with
sarcopenia, and this value was found to higher in non-sarcopenic
patients (Table 2). SMI was lower in patients over the age of 70
compared to those older than 40 (p <0.05) (Table 3).